EP1005360A4 - Proteine anti-oxydante 2, gene et procedes d'utilisation correspondants - Google Patents

Proteine anti-oxydante 2, gene et procedes d'utilisation correspondants

Info

Publication number
EP1005360A4
EP1005360A4 EP98919730A EP98919730A EP1005360A4 EP 1005360 A4 EP1005360 A4 EP 1005360A4 EP 98919730 A EP98919730 A EP 98919730A EP 98919730 A EP98919730 A EP 98919730A EP 1005360 A4 EP1005360 A4 EP 1005360A4
Authority
EP
European Patent Office
Prior art keywords
gene
methods
use therefor
antioxidant protein
antioxidant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98919730A
Other languages
German (de)
English (en)
Other versions
EP1005360A1 (fr
Inventor
Beverly Paigen
David R Beier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Jackson Laboratory
Original Assignee
Brigham and Womens Hospital Inc
Jackson Laboratory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc, Jackson Laboratory filed Critical Brigham and Womens Hospital Inc
Publication of EP1005360A1 publication Critical patent/EP1005360A1/fr
Publication of EP1005360A4 publication Critical patent/EP1005360A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP98919730A 1997-04-02 1998-04-01 Proteine anti-oxydante 2, gene et procedes d'utilisation correspondants Withdrawn EP1005360A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4089797P 1997-04-02 1997-04-02
US40897P 1997-04-02
PCT/US1998/006666 WO1998043666A1 (fr) 1997-04-02 1998-04-01 Proteine anti-oxydante 2, gene et procedes d'utilisation correspondants

Publications (2)

Publication Number Publication Date
EP1005360A1 EP1005360A1 (fr) 2000-06-07
EP1005360A4 true EP1005360A4 (fr) 2001-02-07

Family

ID=21913589

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98919730A Withdrawn EP1005360A4 (fr) 1997-04-02 1998-04-01 Proteine anti-oxydante 2, gene et procedes d'utilisation correspondants

Country Status (4)

Country Link
EP (1) EP1005360A4 (fr)
JP (1) JP2001522229A (fr)
CA (1) CA2285631A1 (fr)
WO (1) WO1998043666A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2798672B1 (fr) * 1999-09-17 2003-10-31 Commissariat Energie Atomique Formes acides des peroxyredoxines et leur utilisation comme moyen de diagnostic
AUPR221300A0 (en) 2000-12-20 2001-01-25 Malaysian Palm Oil Board A molecular marker
EP1566182A4 (fr) * 2002-11-10 2009-08-19 Inst Of Cell Biophysics Russia Composition presentant des proprietes antioxydantes, procede de production d'un polypeptide et methode de traitement
WO2012075911A1 (fr) * 2010-12-06 2012-06-14 Li Jianyuan Utilisation d'une protéine prx-6 humaine recombinante dans le traitement d'une brûlure et d'un ébouillantage et/ou d'une lésion cornéenne

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005780A1 (fr) * 1990-10-01 1992-04-16 Brigham And Women's Hospital Therapie a base de beta-carotene et de vitamine e destinee a prevenir les accidents vasculaires majeurs

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005780A1 (fr) * 1990-10-01 1992-04-16 Brigham And Women's Hospital Therapie a base de beta-carotene et de vitamine e destinee a prevenir les accidents vasculaires majeurs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9843666A1 *

Also Published As

Publication number Publication date
CA2285631A1 (fr) 1998-10-08
JP2001522229A (ja) 2001-11-13
EP1005360A1 (fr) 2000-06-07
WO1998043666A1 (fr) 1998-10-08

Similar Documents

Publication Publication Date Title
SG105506A1 (en) Gene sequencer and methods
AU4008495A (en) Tcl-1 gene and protein and related methods and compositions
EP1053315A4 (fr) Gene de la calvitie chez l'homme, proteine et utilisations associees
HUP0100535A3 (en) Hydrophobically-modified protein compositions and methods
AU2861695A (en) Mn gene and protein
AP2001002189A0 (en) Genes and proteins and their uses
AU3241895A (en) Apoptosis related protein bcl-y, and methods of use thereof
IL126923A0 (en) Mammalian tolloid-like gene and protein
AU8168898A (en) Interferon stimulating protein and uses thereof
EP1005360A4 (fr) Proteine anti-oxydante 2, gene et procedes d'utilisation correspondants
AU1456899A (en) Human protein kinase and kinase inhibitors
AU3955099A (en) Novel gene and protein encoded thereby
AU3411999A (en) Novel rnase-like protein and its use
AU5196699A (en) Novel gene and protein pgth encoded thereby
AU1690200A (en) Novel protein and dna thereof
AU7985398A (en) Ga4 homologue dna, protein and methods of use
EP1122312A4 (fr) Nouvelle proteine war-1 et son gene
AU5447999A (en) Novel protein and dna thereof
AU5196799A (en) Novel gene and protein osbh encoded thereby
GB9824569D0 (en) Virulence gene and protein,and their use
AUPP524398A0 (en) Novel gene and protein
PL343000A1 (en) Novel sequence class of genes, corresponding proteins and the use of the same
AU5196599A (en) Novel gene and protein gmp30 encoded thereby
GB9827814D0 (en) Virulence gene and protein and their use
IL129241A0 (en) Nucleotide and protein sequence of mammastatin and methods of use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991101

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 38/43 A, 7A 61K 39/395 B, 7A 61K 48/00 B, 7C 12N 15/11 B, 7C 12N 9/00 B, 7C 12N 15/63 B, 7C 12Q 1/68 B, 7C 12P 19/34 B, 7G 01N 33/53 B, 7C 12N 9/20 B

A4 Supplementary search report drawn up and despatched

Effective date: 20001229

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.

Owner name: THE JACKSON LABORATORY

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041103